IN8bio, Inc.
INAB
$1.80
-$0.11-5.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.44M | -20.66M | -23.89M | -27.43M | -30.44M |
| Total Depreciation and Amortization | 2.50M | 2.68M | 2.85M | 2.69M | 2.66M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.19M | 3.30M | 4.42M | 4.64M | 5.05M |
| Change in Net Operating Assets | 1.04M | 72.00K | -563.00K | 745.00K | -1.41M |
| Cash from Operations | -12.71M | -14.60M | -17.19M | -19.35M | -24.15M |
| Capital Expenditure | -- | -33.00K | -33.00K | -116.00K | -187.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -33.00K | -33.00K | -116.00K | -187.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -693.00K | -801.00K | -891.00K | -831.00K | -794.00K |
| Issuance of Common Stock | 29.33M | 21.96M | 21.13M | 19.19M | 15.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 181.00K | 0.00 | 0.00 | -89.00K |
| Cash from Financing | 28.64M | 21.34M | 20.24M | 18.35M | 14.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.93M | 6.70M | 3.02M | -1.11M | -10.15M |